PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Detail   |   Print    Next page > 
     
Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Asthma
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Ascletis Selects for Clinical Development a Fixed-Dose Combination of First-in-Class Oral Small Molecule GIPR Agonist, ASC48, and Oral Small Molecule GLP-1R Agonist, ASC30
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Asthma
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NATIONAL UNIVERSITY HOSPITAL TO EXPAND WEARABLE TECHNOLOGY FOR PATIENT MONITORING FOLLOWING SUCCESSFUL PILOT
2026-07-15T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
LumaCina Appoints Gary Bird as CEO to Accelerate Growth and Expand Global Sterile Injectables Portfolio
2026-07-15T    Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT$500 million
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ACROBiosystems Obtains PMDA Material Suitability Confirmation for GMP-grade IL-15, Ensuring Reliable Quality and Strengthening the Biopharmaceutical Approval Process
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved